Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The hemolytic-uremic syndrome].

P A Rodrigues1, J Machado, O Cardoso

  • 1Serviço de Medicina, Hospital Curry Cabral, Lisboa.

Acta Medica Portuguesa
|September 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Influence of pre‑analytical factors and biological variability on the urinary volatilome.

Analytical and bioanalytical chemistry·2026
Same author

Bigger isn't always better: Comparing system size, hydration, and software for lipid membrane analysis.

Biochimica et biophysica acta. Biomembranes·2026
Same author

Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project.

ESMO open·2026
Same author

Correction: CAP in the ICU: are they all in fact CAP?

Intensive care medicine·2026
Same author

CAP in the ICU: are they all in fact CAP?

Intensive care medicine·2025
Same author

Influence of pre-analytical factors and biological variability on the urinary volatilome.

Analytical and bioanalytical chemistry·2025

Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are severe microangiopathic thrombotic syndromes. This case highlights the challenges in managing HUS, emphasizing the need for updated treatment strategies for this rare, high-mortality condition.

Area of Science:

  • Nephrology
  • Hematology
  • Pathology

Background:

  • Microangiopathic thrombotic syndromes, including thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), represent a spectrum of rare, life-threatening disorders.
  • These conditions are defined by microangiopathic hemolytic anemia, thrombocytopenia, renal dysfunction, neurological symptoms, and fever, often with high mortality rates despite therapeutic interventions.

Observation:

  • A case of hemolytic uremic syndrome (HUS) in a young adult is presented, initially showing a favorable prognosis based on clinical course and biopsy.
  • The patient experienced an early recurrence of severe hypertension, leading to a fatal outcome within six months.

Findings:

  • The case illustrates the unpredictable and aggressive nature of HUS, even with initial indicators of a positive prognosis.

Related Experiment Videos

  • Recurrent severe hypertension was a critical factor in the unfavorable outcome.

    • Implications:

    • This clinical case underscores the critical need for continuous re-evaluation of prognostic indicators in HUS.
    • It highlights the importance of staying abreast of the latest advancements in the pathogenesis and treatment strategies for TTP-HUS spectrum disorders to improve patient outcomes.